Weill Cornell Medicine Events

Molecular Pharmacology and Chemical Biology Program 

The Mevalonate Pathway: a Rational Target To Enhance Efficacy of BH3 Mimetics in Blood Cancer

       

        David Fruman, Ph.D

 

        Professor, Department of Molecular Biology & Biochemistry

        Associate Director, Cancer Research Institute

        Speaker's Affiliation:   University of California, Irvine

 

        Host:  Dr. Michael Kharas

       

        Tea ?:   Yes

        Tea Time:    Tea at 3:45 PM

 

 

Wednesday, September 26 at 4:00pm to 5:00pm

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, M107
525 E 68th St.

Event Type

Lecture/Seminar

Mission

Education, Research

Subscribe
Google Calendar iCal Outlook

Recent Activity